Sangamo Therapeutics
SGMO
#8422
Rank
โ‚น13.49 B
Marketcap
โ‚น60.06
Share price
2.96%
Change (1 day)
41.26%
Change (1 year)

Revenue for Sangamo Therapeutics (SGMO)

Revenue in 2024 (TTM): โ‚น4.85 Billion

According to Sangamo Therapeutics 's latest financial reports the company's current revenue (TTM ) is โ‚น4.92 Billion. a decrease over the revenue in the year 2023 that were of โ‚น14.67 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Sangamo Therapeutics from 2000 to 2024

Annual revenue

Year Revenue Change
2024 โ‚น4.95 B-66.2%
2023 โ‚น14.67 B59.3%
2022 โ‚น9.20 B11.78%
2021 โ‚น8.23 B-4.68%
2020 โ‚น8.64 B18.34%
2019 โ‚น7.30 B23.69%
2018 โ‚น5.90 B152.91%
2017 โ‚น2.33 B77.21%
2016 โ‚น1.31 B-49.86%
2015 โ‚น2.62 B-9.62%
2014 โ‚น2.90 B94.99%
2013 โ‚น1.49 B25.75%
2012 โ‚น1.18 B117.21%
2011 โ‚น0.54 B-41.45%
2010 โ‚น0.93 B-9.44%
2009 โ‚น1.02 B32.33%
2008 โ‚น0.77 B117.89%
2007 โ‚น0.35 B2.24%
2006 โ‚น0.34 B212.55%
2005 โ‚น0.11 B96.2%
2004 โ‚น56.95 M-51.5%
2003 โ‚น0.11 B-43.62%
2002 โ‚น0.20 B-11.64%
2001 โ‚น0.23 B47.11%
2000 โ‚น0.16 B

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
โ‚น2.447 T 49,645.67%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น191.38 B 3,789.69%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น2.845 T 57,726.99%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น823.66 B 16,640.31%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น3.657 T 74,232.18%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น7.560 T 153,569.55%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น242.93 B 4,837.57%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น5.462 T 110,917.30%๐Ÿ‡บ๐Ÿ‡ธ USA